Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-005005
Filing Date
2015-05-26
Accepted
2015-05-26 16:00:21
Documents
5
Period of Report
2015-07-07
Effectiveness Date
2015-05-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2224850zdef14a.htm DEF 14A 582690
2 G832997.JPG g832997.jpg GRAPHIC 9252
3 G831591.JPG g831591.jpg GRAPHIC 3461
4 G111862BGI001.GIF g111862bgi001.gif GRAPHIC 121472
5 G111862BGI002.GIF g111862bgi002.gif GRAPHIC 79518
  Complete submission text file 0001047469-15-005005.txt   878765
Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35798 | Film No.: 15889343
SIC: 2834 Pharmaceutical Preparations